Subependymal Giant Cell Astrocytoma Presenting with Tumoral Bleeding: A Case Report

Overview

Journal Brain Tumor Res Treat

Date 2017 May 19

PMID 28516078

Citations 7

Authors

Jae-Young Kim

Tae-Young Jung

Kyung-Hwa Lee

Seul-Kee Kim

Affiliations

Soon will be listed here.

Abstract

We report a rare case of subependymal giant cell astrocytoma (SEGA) associated with tumoral bleeding in a pediatric patient without tuberous sclerosis complex (TSC). A 10-year-old girl presented with a 2-week history of an increasingly aggravating headache. Brain magnetic resonance imaging revealed an approximately 3.6-cm, well-defined, heterogeneously enhancing mass with multistage hemorrhages on the right-sided foramen of Monro. The tumor was completely resected using a transcallosal approach. Intraoperatively, the mass presented as a gray-colored firm tumor associated with acute and subacute hemorrhages. The origin of the mass was identified as the ventricular septum adjacent to the foramen of Monro. A pathological analysis revealed pleomorphic multinucleated eosinophilic tumor cells with abundant cytoplasm. These cells showed positive staining for the glial fibrillary acidic protein and S100 protein. A diagnosis of SEGA was established. The patient recovered without any neurological symptoms. There was no evidence of TSC. The radiological follow-up showed no recurrence for 2 years. This was a case of SEGA with intratumoral hemorrhage, for which a favorable outcome was achieved, without any neurological deficit after tumoral resection.

Citing Articles

Detecting Tumor-Associated Intracranial Hemorrhage Using Proton Magnetic Resonance Spectroscopy.

Yoo H, Lee H, Nga V, Choi Y, Lim J Neurol Int. 2024; 16(6):1856-1877.

PMID: 39728759 PMC: 11679972. DOI: 10.3390/neurolint16060133.

Bleeding solitary SEGA in non-tuberous sclerosis complex adolescent: a case illustration and review of literature.

Yindeedej V, Rojnueangnit K, Chotsakulthong P, Thamwongskul C Childs Nerv Syst. 2024; 40(7):2199-2207.

PMID: 38578478 DOI: 10.1007/s00381-024-06382-z.

Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review.

Cobourn K, Chesney K, Mueller K, Fayed I, Tsering D, Keating R Childs Nerv Syst. 2023; 40(1):73-78.

PMID: 37658938 DOI: 10.1007/s00381-023-06105-w.

Subependymal Giant Cell Astrocytoma Apoplexy: A Case Report and Systematic Review.

Turkistani A, Fallatah M, Ghoneim A, Alghamdi F, Baeesa S Cureus. 2023; 15(2):e34784.

PMID: 36915840 PMC: 10006398. DOI: 10.7759/cureus.34784.

Trends in survival and treatment of SEGA: National Cancer Database Analysis.

Ryoo J, Khalid S, Chaker A, Behbahani M, Nunna R, Mehta A Neurooncol Pract. 2021; 8(1):98-105.

PMID: 33664974 PMC: 7906259. DOI: 10.1093/nop/npaa060.

References

Stavrinou P, Spiliotopoulos A, Patsalas I, Balogiannis I, Karkavelas G, Polyzoidis K . Subependymal giant cell astrocytoma with intratumoral hemorrhage in the absence of tuberous sclerosis. J Clin Neurosci. 2008; 15(6):704-6. DOI: 10.1016/j.jocn.2007.06.003. View

Ogiwara H, Morota N . Subependymal giant cell astrocytoma with intratumoral hemorrhage. J Neurosurg Pediatr. 2013; 11(4):469-72. DOI: 10.3171/2013.1.PEDS12403. View

Dabora S, Jozwiak S, Franz D, Roberts P, Nieto A, Chung J . Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 2000; 68(1):64-80. PMC: 1234935. DOI: 10.1086/316951. View

Barbosa-Coutinho L, Lima E, Gadret R, Ferreira N . [Massive intratumor hemorrhage in tuberous sclerosis. Autopsy study of a case]. Arq Neuropsiquiatr. 1991; 49(4):465-70. DOI: 10.1590/s0004-282x1991000400018. View

Wakai S, Yamakawa K, Manaka S, Takakura K . Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical significance. Neurosurgery. 1982; 10(4):437-44. DOI: 10.1227/00006123-198204000-00004. View

Beaumont T, Limbrick D, Smyth M . Advances in the management of subependymal giant cell astrocytoma. Childs Nerv Syst. 2012; 28(7):963-8. DOI: 10.1007/s00381-012-1785-x. View

Henderson M, Fakiris A, Timmerman R, Worth R, Lo S, Witt T . Gamma knife stereotactic radiosurgery for low-grade astrocytomas. Stereotact Funct Neurosurg. 2009; 87(3):161-7. DOI: 10.1159/000209297. View

Park K, Kano H, Kondziolka D, Niranjan A, Flickinger J, Lunsford L . Gamma Knife surgery for subependymal giant cell astrocytomas. Clinical article. J Neurosurg. 2010; 114(3):808-13. DOI: 10.3171/2010.9.JNS10816. View

Park Y, Kim E, Chang J, Chung S . Volume changes following gamma knife radiosurgery of intracranial tumors. Surg Neurol. 1997; 48(5):488-93. DOI: 10.1016/s0090-3019(97)00186-9. View

10.

Kalina P, Drehobl K, Greenberg R, Black K, HYMAN R . Hemorrhagic subependymal giant cell astrocytoma. Pediatr Radiol. 1995; 25(1):66-7. DOI: 10.1007/BF02020855. View

11.

Hamamoto O, Honorato D, Brito H . [Intratumor hemorrhage in tuberous sclerosis. A case report]. Arq Neuropsiquiatr. 1994; 52(3):435-8. DOI: 10.1590/s0004-282x1994000300026. View

12.

Sterman H, Beer Furlan A, Matushita H, Teixeira M . Subependymal giant cell astrocytoma associated with tuberous sclerosis presenting with intratumoral bleeding. Case report and review of literature. Childs Nerv Syst. 2012; 29(2):335-9. DOI: 10.1007/s00381-012-1962-y. View

13.

Adriaensen M, Schaefer-Prokop C, Stijnen T, Duyndam D, Zonnenberg B, Prokop M . Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur J Neurol. 2009; 16(6):691-6. DOI: 10.1111/j.1468-1331.2009.02567.x. View

14.

Kwiatkowska J, Wigowska-Sowinska J, Napierala D, Slomski R, Kwiatkowski D . Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis. N Engl J Med. 1999; 340(9):703-7. DOI: 10.1056/NEJM199903043400905. View

15.

Franz D, Belousova E, Sparagana S, Bebin E, Frost M, Kuperman R . Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2012; 381(9861):125-32. DOI: 10.1016/S0140-6736(12)61134-9. View

16.

Northrup H, Krueger D . Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013; 49(4):243-54. PMC: 4080684. DOI: 10.1016/j.pediatrneurol.2013.08.001. View

17.

Krueger D, Care M, Holland K, Agricola K, Tudor C, Mangeshkar P . Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med. 2010; 363(19):1801-11. DOI: 10.1056/NEJMoa1001671. View

18.

Franz D, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G . Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol. 2006; 59(3):490-8. DOI: 10.1002/ana.20784. View

19.

Au K, Williams A, Gambello M, Northrup H . Molecular genetic basis of tuberous sclerosis complex: from bench to bedside. J Child Neurol. 2004; 19(9):699-709. DOI: 10.1177/08830738040190091101. View

20.

Ichikawa T, Wakisaka A, Daido S, Takao S, Tamiya T, Date I . A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism. J Mol Diagn. 2005; 7(4):544-9. PMC: 1888498. DOI: 10.1016/S1525-1578(10)60586-7. View